News & Insights  |  Press Releases

Related Professionals

Practice Areas


Patricia O'Connell
Senior Communications Manager

Wiley Rein’s Lawrence M. Sung Authors Handbook on U.S. Patent Law Developments

October 24, 2014

Dr. Lawrence M. Sung, a partner in Wiley Rein LLP’s Intellectual Property Practice, has co-authored the Patent Law Handbook (2014-2015 edition, Intellectual Property), published by Thomson Reuters, which covers significant new developments in patent law.

Dr. Sung is a registered patent attorney with a Ph.D. in microbiology who has over 20 years of experience in biotechnology, medical device, and pharmaceutical patent counseling, litigation, and technology transfer.  Having served on several professional school faculties, he is also a recognized intellectual property law scholar.

This comprehensive handbook will help attorneys discern what the courts may find, while also providing immediate access to current law.  It provides easy access to information on validity; inequitable conduct; defenses and counterclaims; infringement; willful infringement; remedies; appeal; pretrial and trial issues; U.S. Patent and Trademark Office proceedings; licensing; and patent proceedings in other forms, including International Trade Commission (ITC) proceedings and claims court.  The treatise also analyzes the Federal Circuit’s approach to statutory subject matter as it relates to computer software, its decision clarifying the role of judges and juries in interpreting claims, and its holdings in other opinions.

Features include:

  • Precedents addressing individual cases
  • An examination of recent patent law cases to analyze trends and issues
  • Immediate access to law through extensive use of footnotes
  • Quick facts and answers to patent law questions based upon recent decisions

Dr. Sung is a member of a biotech patent group—also including partners A. Neal Seth and Mary Sylvia—that joined Wiley Rein earlier this year.  The team—which brings a dynamic combination of scientific credentials and legal acumen—advises clients on patent litigation strategy and appeals, patent prosecution and portfolio matters, dispute settlements, and technology transfer in the biotechnology, pharmaceutical, medical devices, and chemical industries.